学术探索
学术期刊
新闻热点
数据分析
智能评审
立即登录
CURRENT APPROACHES TO THE THERAPY OF FIBROTIC DISEASES
被引:24
作者
:
FRANKLIN, TJ
论文数:
0
引用数:
0
h-index:
0
机构:
Cancer Research Department, Zeneca Pharmaceuticals, Macclesfield
FRANKLIN, TJ
机构
:
[1]
Cancer Research Department, Zeneca Pharmaceuticals, Macclesfield
来源
:
BIOCHEMICAL PHARMACOLOGY
|
1995年
/ 49卷
/ 03期
关键词
:
FIBROSIS;
INFLAMMATION;
CYTOKINES;
SIGNAL TRANSDUCTION;
RECEPTOR TYROSINE KINASES;
TYRPHOSTINS;
EXTRACELLULAR MATRIX;
COLLAGEN;
COLLAGENASE;
PROLYL;
4-HYDROXYLASE;
LYSYL OXIDASE;
D O I
:
10.1016/0006-2952(94)00354-O
中图分类号
:
R9 [药学];
学科分类号
:
1007 ;
摘要
:
[No abstract available]
引用
收藏
页码:267 / 273
页数:7
相关论文
共 63 条
[1]
Absher Marlene, 1993, Regional Immunology, V5, P225
[2]
ANDERSON S, 1986, J CLIN INVEST, V77, P1193
[3]
BARKER AJ, 1994, BR J CANCER S21, V64, P18
[4]
BENEFICIAL-EFFECTS OF INHIBITORS OF PROLYL 4-HYDROXYLASE IN CCL4-INDUCED FIBROSIS OF THE LIVER IN RATS
BICKEL, M
论文数:
0
引用数:
0
h-index:
0
机构:
Hoechst, AG, Pharma Research, Frankfurt
BICKEL, M
BAADER, E
论文数:
0
引用数:
0
h-index:
0
机构:
Hoechst, AG, Pharma Research, Frankfurt
BAADER, E
BROCKS, DG
论文数:
0
引用数:
0
h-index:
0
机构:
Hoechst, AG, Pharma Research, Frankfurt
BROCKS, DG
ENGELBART, K
论文数:
0
引用数:
0
h-index:
0
机构:
Hoechst, AG, Pharma Research, Frankfurt
ENGELBART, K
GUNZLER, V
论文数:
0
引用数:
0
h-index:
0
机构:
Hoechst, AG, Pharma Research, Frankfurt
GUNZLER, V
SCHMIDTS, HL
论文数:
0
引用数:
0
h-index:
0
机构:
Hoechst, AG, Pharma Research, Frankfurt
SCHMIDTS, HL
VOGEL, GH
论文数:
0
引用数:
0
h-index:
0
机构:
Hoechst, AG, Pharma Research, Frankfurt
VOGEL, GH
[J].
JOURNAL OF HEPATOLOGY,
1991,
13
: S26
-
S34
[5]
DECLINING INCIDENCE OF NEPHROPATHY IN INSULIN-DEPENDENT DIABETES-MELLITUS
BOJESTIG, M
论文数:
0
引用数:
0
h-index:
0
机构:
EKSJO NASSJO HOSP,DEPT INTERNAL MED,EKSJO,SWEDEN
BOJESTIG, M
ARNQVIST, HJ
论文数:
0
引用数:
0
h-index:
0
机构:
EKSJO NASSJO HOSP,DEPT INTERNAL MED,EKSJO,SWEDEN
ARNQVIST, HJ
HERMANSSON, G
论文数:
0
引用数:
0
h-index:
0
机构:
EKSJO NASSJO HOSP,DEPT INTERNAL MED,EKSJO,SWEDEN
HERMANSSON, G
KARLBERG, BE
论文数:
0
引用数:
0
h-index:
0
机构:
EKSJO NASSJO HOSP,DEPT INTERNAL MED,EKSJO,SWEDEN
KARLBERG, BE
LUDVIGSSON, J
论文数:
0
引用数:
0
h-index:
0
机构:
EKSJO NASSJO HOSP,DEPT INTERNAL MED,EKSJO,SWEDEN
LUDVIGSSON, J
[J].
NEW ENGLAND JOURNAL OF MEDICINE,
1994,
330
(01)
: 15
-
18
[6]
BORDER WA, 1994, EXP NEPHROL, V2, P13
[7]
SUPPRESSION OF EXPERIMENTAL GLOMERULONEPHRITIS BY ANTISERUM AGAINST TRANSFORMING GROWTH FACTOR-BETA-1
BORDER, WA
论文数:
0
引用数:
0
h-index:
0
机构:
LA JOLLA CANC RES FDN,CANC RES CTR,LA JOLLA,CA 92037
BORDER, WA
OKUDA, S
论文数:
0
引用数:
0
h-index:
0
机构:
LA JOLLA CANC RES FDN,CANC RES CTR,LA JOLLA,CA 92037
OKUDA, S
LANGUINO, LR
论文数:
0
引用数:
0
h-index:
0
机构:
LA JOLLA CANC RES FDN,CANC RES CTR,LA JOLLA,CA 92037
LANGUINO, LR
SPORN, MB
论文数:
0
引用数:
0
h-index:
0
机构:
LA JOLLA CANC RES FDN,CANC RES CTR,LA JOLLA,CA 92037
SPORN, MB
RUOSLAHTI, E
论文数:
0
引用数:
0
h-index:
0
机构:
LA JOLLA CANC RES FDN,CANC RES CTR,LA JOLLA,CA 92037
RUOSLAHTI, E
[J].
NATURE,
1990,
346
(6282)
: 371
-
374
[8]
NATURAL INHIBITOR OF TRANSFORMING GROWTH-FACTOR-BETA PROTECTS AGAINST SCARRING IN EXPERIMENTAL KIDNEY-DISEASE
BORDER, WA
论文数:
0
引用数:
0
h-index:
0
机构:
TELIOS PHARMACEUT INC,SAN DIEGO,CA 92121
BORDER, WA
NOBLE, NA
论文数:
0
引用数:
0
h-index:
0
机构:
TELIOS PHARMACEUT INC,SAN DIEGO,CA 92121
NOBLE, NA
YAMAMOTO, T
论文数:
0
引用数:
0
h-index:
0
机构:
TELIOS PHARMACEUT INC,SAN DIEGO,CA 92121
YAMAMOTO, T
HARPER, JR
论文数:
0
引用数:
0
h-index:
0
机构:
TELIOS PHARMACEUT INC,SAN DIEGO,CA 92121
HARPER, JR
YAMAGUCHI, Y
论文数:
0
引用数:
0
h-index:
0
机构:
TELIOS PHARMACEUT INC,SAN DIEGO,CA 92121
YAMAGUCHI, Y
PIERSCHBACHER, MD
论文数:
0
引用数:
0
h-index:
0
机构:
TELIOS PHARMACEUT INC,SAN DIEGO,CA 92121
PIERSCHBACHER, MD
RUOSLAHTI, E
论文数:
0
引用数:
0
h-index:
0
机构:
TELIOS PHARMACEUT INC,SAN DIEGO,CA 92121
RUOSLAHTI, E
[J].
NATURE,
1992,
360
(6402)
: 361
-
364
[9]
CYTOKINES IN KIDNEY-DISEASE - THE ROLE OF TRANSFORMING GROWTH-FACTOR-BETA
BORDER, WA
论文数:
0
引用数:
0
h-index:
0
机构:
Division of Nephrology, University of Utah School of Medicine, Salt Lake City, Utah
BORDER, WA
NOBLE, NA
论文数:
0
引用数:
0
h-index:
0
机构:
Division of Nephrology, University of Utah School of Medicine, Salt Lake City, Utah
NOBLE, NA
[J].
AMERICAN JOURNAL OF KIDNEY DISEASES,
1993,
22
(01)
: 105
-
113
[10]
BRILLA CG, 1993, EUR HEART J, V14, P57
←
1
2
3
4
5
6
7
→
共 63 条
[1]
Absher Marlene, 1993, Regional Immunology, V5, P225
[2]
ANDERSON S, 1986, J CLIN INVEST, V77, P1193
[3]
BARKER AJ, 1994, BR J CANCER S21, V64, P18
[4]
BENEFICIAL-EFFECTS OF INHIBITORS OF PROLYL 4-HYDROXYLASE IN CCL4-INDUCED FIBROSIS OF THE LIVER IN RATS
BICKEL, M
论文数:
0
引用数:
0
h-index:
0
机构:
Hoechst, AG, Pharma Research, Frankfurt
BICKEL, M
BAADER, E
论文数:
0
引用数:
0
h-index:
0
机构:
Hoechst, AG, Pharma Research, Frankfurt
BAADER, E
BROCKS, DG
论文数:
0
引用数:
0
h-index:
0
机构:
Hoechst, AG, Pharma Research, Frankfurt
BROCKS, DG
ENGELBART, K
论文数:
0
引用数:
0
h-index:
0
机构:
Hoechst, AG, Pharma Research, Frankfurt
ENGELBART, K
GUNZLER, V
论文数:
0
引用数:
0
h-index:
0
机构:
Hoechst, AG, Pharma Research, Frankfurt
GUNZLER, V
SCHMIDTS, HL
论文数:
0
引用数:
0
h-index:
0
机构:
Hoechst, AG, Pharma Research, Frankfurt
SCHMIDTS, HL
VOGEL, GH
论文数:
0
引用数:
0
h-index:
0
机构:
Hoechst, AG, Pharma Research, Frankfurt
VOGEL, GH
[J].
JOURNAL OF HEPATOLOGY,
1991,
13
: S26
-
S34
[5]
DECLINING INCIDENCE OF NEPHROPATHY IN INSULIN-DEPENDENT DIABETES-MELLITUS
BOJESTIG, M
论文数:
0
引用数:
0
h-index:
0
机构:
EKSJO NASSJO HOSP,DEPT INTERNAL MED,EKSJO,SWEDEN
BOJESTIG, M
ARNQVIST, HJ
论文数:
0
引用数:
0
h-index:
0
机构:
EKSJO NASSJO HOSP,DEPT INTERNAL MED,EKSJO,SWEDEN
ARNQVIST, HJ
HERMANSSON, G
论文数:
0
引用数:
0
h-index:
0
机构:
EKSJO NASSJO HOSP,DEPT INTERNAL MED,EKSJO,SWEDEN
HERMANSSON, G
KARLBERG, BE
论文数:
0
引用数:
0
h-index:
0
机构:
EKSJO NASSJO HOSP,DEPT INTERNAL MED,EKSJO,SWEDEN
KARLBERG, BE
LUDVIGSSON, J
论文数:
0
引用数:
0
h-index:
0
机构:
EKSJO NASSJO HOSP,DEPT INTERNAL MED,EKSJO,SWEDEN
LUDVIGSSON, J
[J].
NEW ENGLAND JOURNAL OF MEDICINE,
1994,
330
(01)
: 15
-
18
[6]
BORDER WA, 1994, EXP NEPHROL, V2, P13
[7]
SUPPRESSION OF EXPERIMENTAL GLOMERULONEPHRITIS BY ANTISERUM AGAINST TRANSFORMING GROWTH FACTOR-BETA-1
BORDER, WA
论文数:
0
引用数:
0
h-index:
0
机构:
LA JOLLA CANC RES FDN,CANC RES CTR,LA JOLLA,CA 92037
BORDER, WA
OKUDA, S
论文数:
0
引用数:
0
h-index:
0
机构:
LA JOLLA CANC RES FDN,CANC RES CTR,LA JOLLA,CA 92037
OKUDA, S
LANGUINO, LR
论文数:
0
引用数:
0
h-index:
0
机构:
LA JOLLA CANC RES FDN,CANC RES CTR,LA JOLLA,CA 92037
LANGUINO, LR
SPORN, MB
论文数:
0
引用数:
0
h-index:
0
机构:
LA JOLLA CANC RES FDN,CANC RES CTR,LA JOLLA,CA 92037
SPORN, MB
RUOSLAHTI, E
论文数:
0
引用数:
0
h-index:
0
机构:
LA JOLLA CANC RES FDN,CANC RES CTR,LA JOLLA,CA 92037
RUOSLAHTI, E
[J].
NATURE,
1990,
346
(6282)
: 371
-
374
[8]
NATURAL INHIBITOR OF TRANSFORMING GROWTH-FACTOR-BETA PROTECTS AGAINST SCARRING IN EXPERIMENTAL KIDNEY-DISEASE
BORDER, WA
论文数:
0
引用数:
0
h-index:
0
机构:
TELIOS PHARMACEUT INC,SAN DIEGO,CA 92121
BORDER, WA
NOBLE, NA
论文数:
0
引用数:
0
h-index:
0
机构:
TELIOS PHARMACEUT INC,SAN DIEGO,CA 92121
NOBLE, NA
YAMAMOTO, T
论文数:
0
引用数:
0
h-index:
0
机构:
TELIOS PHARMACEUT INC,SAN DIEGO,CA 92121
YAMAMOTO, T
HARPER, JR
论文数:
0
引用数:
0
h-index:
0
机构:
TELIOS PHARMACEUT INC,SAN DIEGO,CA 92121
HARPER, JR
YAMAGUCHI, Y
论文数:
0
引用数:
0
h-index:
0
机构:
TELIOS PHARMACEUT INC,SAN DIEGO,CA 92121
YAMAGUCHI, Y
PIERSCHBACHER, MD
论文数:
0
引用数:
0
h-index:
0
机构:
TELIOS PHARMACEUT INC,SAN DIEGO,CA 92121
PIERSCHBACHER, MD
RUOSLAHTI, E
论文数:
0
引用数:
0
h-index:
0
机构:
TELIOS PHARMACEUT INC,SAN DIEGO,CA 92121
RUOSLAHTI, E
[J].
NATURE,
1992,
360
(6402)
: 361
-
364
[9]
CYTOKINES IN KIDNEY-DISEASE - THE ROLE OF TRANSFORMING GROWTH-FACTOR-BETA
BORDER, WA
论文数:
0
引用数:
0
h-index:
0
机构:
Division of Nephrology, University of Utah School of Medicine, Salt Lake City, Utah
BORDER, WA
NOBLE, NA
论文数:
0
引用数:
0
h-index:
0
机构:
Division of Nephrology, University of Utah School of Medicine, Salt Lake City, Utah
NOBLE, NA
[J].
AMERICAN JOURNAL OF KIDNEY DISEASES,
1993,
22
(01)
: 105
-
113
[10]
BRILLA CG, 1993, EUR HEART J, V14, P57
←
1
2
3
4
5
6
7
→